P2rx7 deletion or pharmacological blockade led to clinical amelioration of IBD, reduced inflammation, and prevented disease onset in different murine models of colitis induced by dextran sulfate sodium (DSS) or 2,4,6-trinitrobenzene sulfonic acid (TNBS) administration [117,118,119]. The gene discussed is P2RX7; the disease is colitis.